Sagimet Biosciences (SGMT) Interest Expenses (2022 - 2026)

Sagimet Biosciences' Interest Expenses history runs 5 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 7565.38% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 7565.38% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, down 94.28% from the prior year.
• Interest Expenses retreated to $2.0 million in Q1 2026 per SGMT's latest filing, from $3.8 million in the prior quarter.
• Across five years, Interest Expenses topped out at $66.4 million in Q4 2024 and bottomed at $8000.0 in Q1 2024.
• The 5-year median for Interest Expenses is $5.5 million (2022), against an average of $15.7 million.
• Across the five-year window, Interest Expenses sank 99.75% in 2024 and surged 19837.04% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $4.0 million in 2022, then soared by 1278.54% to $55.1 million in 2023, then climbed by 20.46% to $66.4 million in 2024, then slumped by 94.28% to $3.8 million in 2025, then tumbled by 47.54% to $2.0 million in 2026.
• Per Business Quant, the three latest SGMT Interest Expenses figures stand at $2.0 million (Q1 2026), $3.8 million (Q4 2025), and $7.0 million (Q3 2025).